Clinical Trial Update: Bone Marrow Transplant in Treating Patients With Hematologic Cancers [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on bone marrow transplant for hematologic cancers (completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Multiple Myeloma and Malignant Plasma Cell Neoplasms
• Myelodysplastic Myeloproliferative Neoplasms
• Myelodysplastic Syndromes
• Myeloproliferative Disorders

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Chronic Myeloproliferative Disorders, Leukemia | Phase 2 | Status: COMPLETED